Table 2 Polygenic prediction of specific side effects across medications.
From: Understanding genetic risk factors for common side effects of antidepressant medications
Antidepressant | BMI PRS predicting weight gain | Insomnia PRS predicting trouble sleeping | Headaches PRS predicting headaches | ||||||
---|---|---|---|---|---|---|---|---|---|
OR (95%C.I.) | P-value | Variance explained (%) | OR (95%C.I.) | P-value | Variance explained (%) | OR (95%C.I.) | P-value | Variance explained (%) | |
Sertraline | 1.24 (1.17–1.32) | 4.66e-12 | 1.25 | 1.06 (0.99–1.14) | 0.077 | 0.09 | 1.16 (1.08–1.25) | 8.17e-05 | 0.49 |
Escitalopram | 1.21 (1.13–1.29) | 3.58e-08 | 1.01 | 1.12 (1.03–1.21) | 0.008 | 0.27 | 1.06 (0.97–1.16) | 0.178 | 0.08 |
Venlafaxine | 1.20 (1.12–1.28) | 3.72e-07 | 0.93 | 1.03 (0.95–1.11) | 0.463 | 0.02 | 1.11 (1.01–1.21) | 0.025 | 0.22 |
Amitriptyline | 1.25 (1.12–1.40) | 9.84e-05 | 1.38 | 1.28 (1.07–1.52) | 0.007 | 1.03 | 1.09 (0.93–1.28) | 0.268 | 0.15 |
Mirtazapine | 1.20 (1.09–1.32) | 2.03e-04 | 0.95 | 1.03 (0.88–1.20) | 0.745 | 0.01 | 1.04 (0.90–1.20) | 0.560 | 0.04 |
Desvenlafaxine | 1.22 (1.11–1.33) | 3.01e-05 | 1.03 | 1.13 (1.03–1.25) | 0.015 | 0.38 | 1.08 (0.98–1.20) | 0.126 | 0.16 |
Citalopram | 1.37 (1.24–1.50) | 9.06e-11 | 2.5 | 1.08 (0.96–1.21) | 0.194 | 0.12 | 1.11 (0.98–1.26) | 0.088 | 0.23 |
Fluoxetine | 1.26 (1.17–1.36) | 5.75e-09 | 1.42 | 1.03 (0.94–1.13) | 0.523 | 0.02 | 1.02 (0.93–1.12) | 0.689 | 0.01 |
Duloxetine | 1.20 (1.08–1.32) | 3.60e-04 | 0.94 | 1.14 (1.02–1.28) | 0.026 | 0.4 | 1.03 (0.92–1.15) | 0.626 | 0.02 |
Paroxetine | 1.22 (1.09–1.36) | 6.28e-04 | 1.1 | 1.16 (1.01–1.33) | 0.042 | 0.47 | 1.16 (1.00–1.35) | 0.053 | 0.46 |